Bank of Nova Scotia
BLU

Bank of Nova Scotia’s BELLUS Health Inc. BLU Stock Holding History

Bank of Nova Scotia’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,850
Closed -$174K – 1255
2022
Q2 		$174K Sell
18,850
-3,000
-14% -$24.5K ﹤0.01% 1125
2022
Q1 		$151K Buy
+21,850
New +$141K ﹤0.01% 1157

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of Nova Scotia's BLU Position: Q3 2022 in Review

Bank of Nova Scotia sold out of BELLUS Health Inc. (BLU) in Q3 2022, closing a stake of 18,850 shares — an estimated $174K sold.

Bank of Nova Scotia first reported a position in BLU in Q1 2022 and held it in 2 quarters. The position peaked at $174K in Q2 2022. 116 funds tracked by Wall St. Rank hold BLU as of Q3 2022.

  • Bank of Nova Scotia reported no remaining BELLUS Health Inc. position as of Q3 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 18,850 BELLUS Health Inc. shares in Q3 2022, an estimated $174K.
  • Bank of Nova Scotia first reported a position in BELLUS Health Inc. in Q1 2022 and held it in 2 quarters.
  • Bank of Nova Scotia's BELLUS Health Inc. position peaked at $174K in Q2 2022.
  • 116 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2022.

Based on Bank of Nova Scotia's 13F filing for Q3 2022, filed 10 Nov 2022.